|
107
|
420
|
6f0oA |
Botulinum neurotoxin a3 hc domain |
|
135
|
421
|
5vgvA |
Structure of the c. botulinum neurotoxin serotype a with cu bound |
|
113
|
431
|
5vmrA |
Receptor binding domain of bont/b in complex with mini-protein binder bot.2110.4 |
|
96
|
429
|
5vidA |
Receptor binding domain of bont/b in complex with mini-protein binder bot.0671.2 |
|
271
|
871
|
5bqnA |
Crystal structure of the lhn fragment of botulinum neurotoxin type d, mutant h233y e230q |
|
302
|
1251
|
4zktA |
Crystal structure of the progenitor m complex of clostridium botulinum type e neurotoxin |
|
100
|
403
|
5bqmB |
Crystal structure of sxn101959, a clostridium botulinum neurotoxin type d derivative and targeted secretion inhibitor |
|
147
|
425
|
4el4A |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s/c165s double mutant |
|
148
|
433
|
4ej5A |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a wild-type |
|
144
|
433
|
4elcA |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134 mutant with mtsea modified cys-165 |
|
275
|
913
|
3zusA |
Crystal structure of an engineered botulinum neurotoxin type a- snare23 derivative, lc-a-snap23-hn-a |
|
280
|
944
|
3zurA |
Crystal structure of an engineered botulinum neurotoxin type a- snare23 derivative, lc0-a-snap25-hn-a |
|
273
|
892
|
3zuqA |
Crystal structure of an engineered botulinum neurotoxin type b - derivative, lc-b-gs-hn-b |
|
105
|
413
|
3rsjA |
Structure of hcrf in complex with ganglioside gd1a |
|
89
|
415
|
3rmxA |
Crystal structure of hcr/d f1240a mutant |
|
97
|
415
|
3rmyA |
Crystal structure of hcr/d w1238a mutant |
|
121
|
426
|
5v8pA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
127
|
426
|
5v8uA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
133
|
430
|
5v8rA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
104
|
424
|
5tpbA |
Binding domain of bont/a complexed with ganglioside variant |
|
110
|
425
|
5tpcA |
Binding domain of bont/a complexed with ganglioside |
|
135
|
423
|
4zjxA |
Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with a novel cyclic peptide inhibitor |
|
117
|
442
|
5bqmA |
Crystal structure of sxn101959, a clostridium botulinum neurotoxin type d derivative and targeted secretion inhibitor |
|
103
|
430
|
4kbbA |
Structure of botulinum neurotoxin b binding domain in complex with both synaptotagmin ii and gd1a |
|
132
|
428
|
4ktxA |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 167-174 stretch |
|
144
|
426
|
4kufA |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134 mutant with mtsea modified cys-165 causing stretch disorder |
|
141
|
428
|
4ks6A |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 166-174 stretch |
|
100
|
421
|
4iqpA |
Crystal structure of hcra-w1266a |
|
93
|
421
|
4jraA |
Crystal structure of the botulinum neurotoxin a receptor-binding domain in complex with the luminal domain of sv2c |
|
120
|
427
|
4hevA |
Clostridium botulinum serotype a light chain inhibited by adamantane hydroxamate |
|
146
|
422
|
3qw7A |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rrfc |
|
99
|
428
|
3r4uA |
Cell entry of botulinum neurotoxin type c is dependent upon interaction with two ganglioside molecules |
|
143
|
423
|
3qw5A |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rrgf |
|
94
|
428
|
3r4sA |
Cell entry of botulinum neurotoxin type c is dependent upon interaction with two ganglioside molecules |
|
138
|
422
|
3qw8A |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor crgc |
|
123
|
420
|
3qiyA |
Crystal structure of bont/a lc complexed with hydroxamate-based inhibitor pt-1 |
|
144
|
422
|
3qw6A |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rygc |
|
133
|
420
|
3qizA |
Crystal structure of bont/a lc complexed with hydroxamate-based inhibitor pt-2 |
|
130
|
419
|
3qixA |
Crystal structure of bont/a lc with zinc bound |
|
131
|
419
|
3qj0A |
Crystal structure of bont/a lc complexed with hydroxamate-based inhibitor pt-3 |
|
108
|
414
|
3oggA |
Crystal structure of the receptor binding domain of botulinum neurotoxin d |
|
112
|
420
|
3obrA |
Crystal structure of botulinum neurotoxin serotype d binding domain |
|
104
|
420
|
3obtA |
Crystal structure of botulinum neurotoxin serotype d ligand binding domain in complex with n-acetylneuraminic acid |
|
91
|
424
|
3n7kA |
Crystal structure of botulinum neurotoxin serotype c1 binding domain |
|
94
|
415
|
3n7jA |
Crystal structure of botulinum neurotoxin serotype d binding domain |
|
103
|
433
|
3mppG |
Botulinum neurotoxin type g receptor binding domain |
|
45
|
165
|
3k3qC |
Crystal structure of a llama antibody complexed with the c. botulinum neurotoxin serotype a catalytic domain |
|
64
|
249
|
3k3qB |
Crystal structure of a llama antibody complexed with the c. botulinum neurotoxin serotype a catalytic domain |
|
344
|
1251
|
3ffzA |
Domain organization in clostridium butulinum neurotoxin type e is unique: its implication in faster translocation |
|
105
|
421
|
3fuoA |
The crystal structure of receptor binding domain of botulinum neurotoxin serotype a |
